FDA panel votes against Duchenne muscular dystrophy drug
Tuesday, April 26, 2016 - 09:30
in Health & Medicine
Stephen FellerWASHINGTON, April 26 (UPI) -- An FDA panel voted against approval for the drug eteplirsen to treat Duchenne muscular dystrophy because a trial of the drug had too few patients.